| Answers |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Real Estate > Real Estate > The Correction In The Florida Real Estate Market |
|
Answers - The Correction In The Florida Real Estate Market
The problem with the real estate market in South Florida is that the maj According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product ority of gains were fueled by investors. They bought property at the top ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in Now we are getting close to the bottom. The main problem that they face lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. is that rental prices have not kept up with the rise in home prices. The here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe majority of investors are losing hundreds, if not thousands of dollars d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro month. The question is How Long Can This Go On For. Investors want to ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc et out of their properties, even if they have to take a loss. Also, ther easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi e are a certain number that are willing to give them back to the banks. nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically f these properties are sold below market value, the comps will go down, and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ hus will housing prices. The sad part is that landlords and owners are ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi ot being realistic. They have some inflated idea of their properties val ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a ue and will not lower the price. The end result is that they maintain th dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod ir prices, sit on the property and then reach a point when they are forc cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin d to unload them for less then they could have gotten. Sellers must be tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen educated to the factors affecting the Real Estate Market and to the mark t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel t conditions.
Investors are at the point of trying to determine what ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust hey can sell their properties for and how much loss they will take. They y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products are at the point where they are willing to take the losses due to the f . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de ct that they are afraid that when the market does come back, they will n elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip t be able to make up the losses they have accumulated during this period tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Promoting Your Private Label at Industry Trade Shows Permanent Insurance: Whole, Universal and Variable Really Cheap Car Insurance – Talk with Your Agent
|